US98956P1021
© PR Newswire
22.12.2025
ZBH
LISTED
NYSE
Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
WARSAW, Ind., Dec. 22, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PT (11:15 a.m. ET)....
Themefolio
Profiler
Peergroup
© PR Newswire
17.12.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2025
News Preview
WARSAW, Ind., Dec. 17, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2025. The cash dividend of $0.24 per share is payable on or about January 30, 2...
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2025
ZBH
LISTED
NYSE
Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery
News Preview
OneStep's Clinically Validated Mobility Intelligence Technology to Integrate into Zimmer Biomet's mymobility® Care Management Platform to Further Enhance Recovery MonitoringWARSAW, Ind., Dec. 16, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and OneStep, the FDA-listed digital fall preve...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
14.11.2025
ZBH
LISTED
NYSE
Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology
News Preview
ROSA
® Knee with OptimiZe
™ Offers Personalized Surgical Planning and Drives Confidence in Delivering Accurate and Reproducible Outcomes1
WARSAW, Ind., Nov. 14, 2025 /PRNewswire/ -- Zi...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
13.11.2025
ZBH
LISTED
NYSE
Zimmer Biomet Holdings, Inc. (ZBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZIMMER BIOMET HOLDINGS, INC. (ZBH), CONTACT THE LAW OFFICES OF HOWARD G. SMITH...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ZBH
LISTED
NYSE
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON Z...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ZBH
LISTED
NYSE
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON ZIMMER BIOMET HOLDINGS, INC. (ZBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PU...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ZBH
LISTED
NYSE
Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London
News Preview
WARSAW, Ind., Nov. 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at the Annual Jefferies Global Healthcare Conference in London on Tuesday, Nov. 18, 2025, at Noon GM...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Third Quarter 2025 Financial Results
News Preview
Third quarter net sales of $2.001 billion increased 9.7% on a reported basis, 8.6% on a constant currency1 basis and 5.0% on an organic constant currency1 basis
Third quarter diluted earnings per share were $1.16; adjusted1 diluted earnings per share were $1.90, an increase of 9.2%...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
News Preview
Prioritized Regulatory Review Process in the U.S. Follows Japan PMDA Approval in September
WARSAW, Ind., Oct. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Ad...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2025
ZBH
LISTED
NYSE
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
News Preview
Company to Spotlight Comprehensive Hip & Knee Portfolios and Latest Advancements in Robotics, Including the mBôs™ System Following Recent Acquisition of Monogram Technologies
WARSAW, Ind., Oct. 21, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ZBH
LISTED
NYSE
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases
News Preview
Gorilla® Pilon Fusion Plating System Introduced for Complex Ankle Fusions
Phantom® TTC Trauma Nail Enhances Treatment Options for Complex Hindfoot Injuries
WARSAW, Ind., Oct. 8, 2025 /PRNewswire/ -- Zimmer Biom...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
07.10.2025
ZBH
LISTED
NYSE
Zimmer Biomet Completes Acquisition of Monogram Technologies
News Preview
Transaction creates the
broadest, most flexible portfolio of orthopedic robotics and navigation technologies, including pathway towards the first fully autonomous robotic technology for orthopedic procedures
WARSAW, Ind., Oct. 7, 2025 /PRNewswire/ -- Zimmer B...
Themefolio
Profiler
Peergroup
© PR Newswire
03.10.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results
News Preview
WARSAW, Ind., Oct. 3, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, November 5, 2025 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET....
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System
News Preview
iTaperloc® Complete and iG7™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint Infection after total joint replacement
WARSAW, Ind., Sept. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical t...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ZBH
LISTED
NYSE
Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference
News Preview
WARSAW, Ind., Sept. 4, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its participation in the American Orthopedic Foot and Ankle Society Annual Conference in Savannah, Ga. From September 10-13, 2025, Zimmer Biomet's wholly owned subsidiary, Paragon 28, will feature a sui...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care
News Preview
Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants
Dr. Anand M. Murthi Appointed Chief Medical Advisor, Shoulder, Sports, Extremities, and Trauma (S.E.T.)
WARSAW, Ind., Aug. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today ann...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025
News Preview
WARSAW, Ind., Aug. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2025. The cash dividend of $0.24 per share is payable on or about October 31, 2...
Themefolio
Profiler
Peergroup
© PR Newswire
25.08.2025
ZBH
LISTED
NYSE
Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference
News Preview
WARSAW, Ind., Aug. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Annual Morgan Stanley Healthcare Conference on Monday, September 8, 2025, at 8:30 a.m. ET....
Themefolio
Profiler
Peergroup
© PR Newswire
07.08.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Second Quarter 2025 Financial Results
News Preview
Second quarter net sales of $2.077 billion increased 7.0% on a reported basis, 5.4% on a constant currency1 basis and 2.8% on an organic constant currency1 basisSecond quarter diluted earnings per share were $0.77; adjusted1 diluted earnings per share were $2.07, an increase of 3.0%Company tightens full-year 2025 reported, constant currency1 and...
Themefolio
Profiler
Peergroup
© PR Newswire
22.07.2025
ZBH
LISTED
NYSE
From Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare Profits
News Preview
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc.
VANCOUVER, BC, July 22, 2025 /PRNewswire/ -- USA News Group News Commentary – The AI revolution in healthcare is fully underway, with the potential to save lives and money, but there's still more to come. Healthcare startups are already figuring out how to implement AI to m...
Themefolio
Profiler
Peergroup
© PR Newswire
22.07.2025
ZBH
LISTED
NYSE
From Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare Profits
News Preview
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc.
VANCOUVER, BC, July 22, 2025 /PRNewswire/ -- USA News Group News Commentary – The AI revolution in healthcare is fully underway, with the potential to save lives and money, but there's still more to come. Healthcare startups are already figuring out how to implement AI to m...
Themefolio
Profiler
Peergroup
© PR Newswire
14.07.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
News Preview
Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons' needs
Acquisition expected to be neutral to adjusted earnings per share in 2025 – 2027 and accretive thereafter and to contribute to revenue growth beginning in 2027
WARSAW, Ind. and AUSTIN, Texas, July 14, 202...
Themefolio
Profiler
Peergroup
© PR Newswire
09.07.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2025 Financial Results
News Preview
WARSAW, Ind., July 9, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will be webcast on Thursday, August 7, 2025 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET....
Themefolio
Profiler
Peergroup
© PR Newswire
30.05.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025
News Preview
WARSAW, Ind., May 30, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2025. The cash dividend of $0.24 per share is payable on or about July 31, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
27.05.2025
ZBH
LISTED
NYSE
Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas
News Preview
WARSAW, Ind., May 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kevin Thornal as Group President, Global Businesses and the Americas. Reporting to Chairman-Elect, President and CEO Ivan Tornos, Mr. Thornal will join the Company on July 1, 2025 to o...
Themefolio
Profiler
Peergroup
© PR Newswire
22.05.2025
ZBH
LISTED
NYSE
Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
News Preview
WARSAW, Ind., May 22, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025, at 9:20 a.m. ET....
Themefolio
Profiler
Peergroup
© PR Newswire
05.05.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces First Quarter 2025 Financial Results
News Preview
First quarter net sales of $1.909 billion increased 1.1% and 2.3% on a constant currency1 basisFirst quarter diluted earnings per share were $0.91; adjusted1 diluted earnings per share were $1.81Company updates full-year 2025 reported revenue guidance to include the Paragon 28 acquisition and currency expectations, and full-year 2025 adjusted1 ea...
Themefolio
Profiler
Peergroup
© PR Newswire
21.04.2025
ZBH
LISTED
NYSE
Zimmer Biomet Completes Acquisition of Paragon 28
News Preview
Transaction Further Strengthens Company's Position in High-Growth Foot and Ankle Segment
WARSAW, Ind., April 21, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. ("Zimmer Biomet"; NYSE and SIX: ZBH), a global medical technology leader, today announced it has completed the acquisition of Paragon 28, Inc. ("Paragon 28"...
Themefolio
Profiler
Peergroup
© PR Newswire
10.04.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2025 Financial Results
News Preview
WARSAW, Ind., April 10, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter earnings conference call will be webcast on Monday, May 5, 2025, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET....
Themefolio
Profiler
Peergroup
© PR Newswire
01.04.2025
ZBH
LISTED
NYSE
Zimmer Biomet Receives CE Mark Approval for RibFix Advantage® Fixation System
News Preview
Expanding Thoracic Portfolio
WARSAW, Ind., and ZUG, Switzerland, April 1, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today announced its RibFix Advantage® Fixation System has received CE Mark certification – the first CE Mark for an intrathoracic rib fixation system....
Themefolio
Profiler
Peergroup
© PR Newswire
10.03.2025
ZBH
LISTED
NYSE
Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting
News Preview
Booth Spotlights Comprehensive Hip Portfolio, Newly Launched Knee and Upper Extremities Reconstructive Technologies, Including Recently Cleared Persona® Revision SoluTion™ Femur, and Debut of ZBX™ Ambulatory Surgery Center Solutions
WARSAW, Ind., March 10, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical te...
Themefolio
Profiler
Peergroup
© PR Newswire
07.03.2025
ZBH
LISTED
NYSE
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur
News Preview
A Revision Knee Implant Alternative for Patients with Metal Sensitivities
WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® Revision SoluTion™ Femur, a revision knee implant component...
Themefolio
Profiler
Peergroup
© PR Newswire
06.03.2025
ZBH
LISTED
NYSE
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer
News Preview
WARSAW, Ind., March 6, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kristen Cardillo as Senior Vice President, Chief Communications Officer. Reporting to President and CEO Ivan Tornos, Ms. Cardillo will join the Company on March 10, 2025, to lead Zimm...
Themefolio
Profiler
Peergroup
© PR Newswire
28.02.2025
ZBH
LISTED
NYSE
Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference
News Preview
WARSAW, Ind., Feb. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the 27th Annual Barclays Healthcare Conference on Thursday, March 13, 2025, at 9:30 a.m. ET....
Themefolio
Profiler
Peergroup
© PR Newswire
27.02.2025
ZBH
LISTED
NYSE
Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer
News Preview
WARSAW, Ind., Feb. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Jehanzeb Noor is joining the Company as Senior Vice President, Chief Strategy, Innovation and Business Development Officer. He will report to Ivan Tornos, President and CEO of Zimmer Biomet....
Themefolio
Profiler
Peergroup
© PR Newswire
26.02.2025
ZBH
LISTED
NYSE
Zimmer Biomet Launches You'll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger
News Preview
Schwarzenegger Invites People Living with Joint Pain to Join New Online Community, Share Their Stories and Connect with a Qualified Physician
WARSAW, Ind., Feb. 26, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the launch of the You'll Be Back campaign with the Company's...
Themefolio
Profiler
Peergroup
© PR Newswire
26.02.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025
News Preview
WARSAW, Ind., Feb. 26, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2025. The cash dividend of $0.24 per share is payable on or about April 30, 202...
Themefolio
Profiler
Peergroup
© PR Newswire
25.02.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Upcoming Changes to Company's Board of Directors
News Preview
WARSAW, Ind., Feb. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced upcoming changes to the Company's Board of Directors, including:
Non-Executive Chair...
Themefolio
Profiler
Peergroup
© PR Newswire
16.01.2025
ZBH
LISTED
NYSE
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2024 Financial Results
News Preview
WARSAW, Ind., Jan. 16, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Thursday, February 6, 2025 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET....
Themefolio
Profiler
Peergroup
© PR Newswire
20.12.2024
ZBH
LISTED
NYSE
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
WARSAW, Ind., Dec. 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 8:15 a.m. PT (11:15 a.m. ET)....
Themefolio
Profiler
Peergroup
© PR Newswire
18.12.2024
ZBH
LISTED
NYSE
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
News Preview
WARSAW, Ind., Dec. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2024. The cash dividend of $0.24 per share is payable on or about January 31,...
Themefolio
Profiler
Peergroup
© PR Newswire
13.12.2024
ZBH
LISTED
NYSE
Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement
News Preview
New Anatomically Shaped Asymmetric Stemless Design for Total Shoulder Replacement
WARSAW, Ind., Dec. 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the OsseoFit™ Stemless Shoulder System for total shoulder r...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2024
ZBH
LISTED
NYSE
Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur
News Preview
A Total Knee Replacement Alternative for Patients with Metal and/or Bone Cement Sensitivities
WARSAW, Ind., Dec. 4, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® SoluTion™ Porous Plasma Spray (PPS®) Fem...
Themefolio
Profiler
Peergroup
© PR Newswire
25.11.2024
ZBH
LISTED
NYSE
Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.
News Preview
WARSAW, Ind., Nov. 25, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) Premarket Approval Application (PMA) Supplement approval for the Oxford® Cementless Partial Knee. The approval is based on safety and effectiveness data from an I...
Themefolio
Profiler
Peergroup
© PR Newswire
21.11.2024
ZBH
LISTED
NYSE
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference
News Preview
WARSAW, Ind., Nov. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Citi Global Healthcare Conference on December 5, 2024, with a fireside chat at 8:45 a.m. ET....
Themefolio
Profiler
Peergroup
© PR Newswire
18.11.2024
ZBH
LISTED
NYSE
Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
News Preview
WARSAW, Ind., and ZURICH, Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision Knee System. This addition to the Persona family builds on Zimmer Biomet's commitment to personalized solutions, providing surgeons with advanced to...
Themefolio
Profiler
Peergroup
© PR Newswire
18.11.2024
ZBH
LISTED
NYSE
Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
News Preview
WARSAW, Ind., and ZURICH, Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision Knee System. This addition to the Persona family builds on Zimmer Biomet's commitment to personalized solutions, providing surgeons with advanced to...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2024
ZBH
LISTED
NYSE
Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer
News Preview
Schwarzenegger to Inspire a Bold New Era of Well-being, Active Living and Reinvention to Advance Company's Mission to Alleviate Pain and Improve the Quality of Life for People Around the World
WARSAW, Ind., Nov. 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced a partner...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2024
ZBH
LISTED
NYSE
Zimmer Biomet Announces Third Quarter 2024 Financial Results
News Preview
Third quarter net sales of $1.824 billion increased 4.0% and 4.1% on a constant currency1 basisThird quarter diluted earnings per share were $1.23; adjusted1 diluted earnings per share were $1.74Company updates 2024 financial guidance, reducing and narrowing range for full year outlookWARSAW, Ind., Oct. 30, 2024 /PRNewswire/ -- Zimmer Biomet Hold...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2024
ZBH
LISTED
NYSE
Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting
News Preview
Company's Booth Spotlights Comprehensive Hip Portfolio and Enabling Technologies Including OrthoGrid Hip AI® and HAMMR™ Automated Hip Impaction System
WARSAW, Ind., Oct. 28, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced plans for the broad commercial launch of the Z1™ Fe...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2024
ZBH
LISTED
NYSE
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
News Preview
WARSAW, Ind., Oct. 9, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, October 30, 2024 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET....
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2024
ZBH
LISTED
NYSE
Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations
News Preview
WARSAW, Ind., Sept. 5, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that David DeMartino will join the Company as Senior Vice President, Investor Relations, effective September 9, 2024. He will report to Ivan Tornos, President and CEO of Zimmer Biomet. In his new role,...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2024
ZBH
LISTED
NYSE
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024
News Preview
WARSAW, Ind., Aug. 29, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2024. The cash dividend of $0.24 per share is payable on or about October 31, 2...
Themefolio
Profiler
Peergroup
© PR Newswire
21.08.2024
ZBH
LISTED
NYSE
Zimmer Biomet to Present at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences
News Preview
WARSAW, Ind., Aug. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will present at two upcoming healthcare conferences in September. The team will be presenting at the Wells Fargo 2024 Healthcare Conference on Thursday,...
Themefolio
Profiler
Peergroup
© PR Newswire
08.07.2024
ZBH
LISTED
NYSE
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results
News Preview
WARSAW, Ind., July 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will be webcast on Wednesday, August 7, 2024 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
